GlassScriptPhysician profile
Amanda M Spira
NPI 1730638016
$2,388.84
in general payments reported to CMS, 2019-2025
14 companies · $326 in 2025
The $326 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $419 · 2022: $420 · 2023: $543 · 2024: $681 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,549.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $1,318.56 | 2021-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Silk Road Medical, INC. | $249.44 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Janssen Pharmaceuticals, INC | $198.24 | 2021 | |
| Penumbra, INC. | $165.39 | 2024 | Indigo System |
| Shockwave Medical, INC | $150.09 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Scientific Affairs, LLC | $78.61 | 2022 | |
| Medtronic, INC. | $71.44 | 2023-2025 | Endurant Iis |
| Boston Scientific Corporation | $40.23 | 2025 | Enroute Transcarotid Neuroprotection System |
| Travere Therapeutics, INC. | $26.04 | 2025 | |
| Lemaitre Vascular, INC. | $24.09 | 2021 | |
| Terumo Medical Corporation | $21.12 | 2024 | Azur Cx Detachable |
| Lundbeck LLC | $18.00 | 2025 | Vyepti |
| Smith+Nephew, INC. | $16.38 | 2025 | Collagenase Santyl |
| Astrazeneca Pharmaceuticals LP | $11.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Spira listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.